This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Inhaled steroids and bone mineral density

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There is some evidence that high doses of inhaled corticosteroids (ICS) (>2000 microgrammes/day) may result in significant osteoporosis over a period of several years (1).

  • a large study has investigated the use of ICS and bone mineral density
    • total of 65 225 adults participated in a cross-sectional study in the Nord-Trøndelag Health Study 1995-1997 (2). Those reporting asthma or asthma-related symptoms, were invited to have bone densitometry of the forearm, flow volume spirometry and a personal interview.
    • altogether 4482 women and 4142 men participated, of whom 2113 reported ever use and 6511 never use of ICS
    • bone mineral density (BMD) of the forearm was compared between 2113 users and 6511 never users of inhaled corticosteroid (ICS)
      • compared to never-users, users of ICS alone or combined with courses of prednisolone had 1.6% lower BMD and users of prednisolone >= 6 months had 7.7% lower BMD both at the distal and ultradistal site
      • no dose-response association was found between daily dose, duration of use or cumulative dose of ICS and BMD
        • study authors noted that lack of dose response between ICS and BMD in the present study could be due to a narrow range of doses in this population, as only 10% of ICS users reported daily doses >=900 microgrammes/day

A large general practice-based cohort study (3) in the UK involving 1,183,663 women and 1,174,234 men showed that people with a history of asthma had an increased risk of fracture. The adjusted hazard ratio was 1.29 (95% CI 1.22 to 1.36) for any fracture and 1.32 (95% CI 1.21 to 1.44) for hip fracture in women and similar in men.

People over the age of 50 with asthma may be considered for fracture-risk assessment, particularly in the presence of other risk factors (4).

Reference:

  • 1) Wong, CA, Walsh, LJ et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000;355:1399-403.
  • 2) Langhammer A et al. Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study). Pharmacoepidemiology and Drug Safety 2004;13 (8): 569-579
  • 3) Hippisley-Cox J, Coupland C. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.
    BMJ 2009;339:b4229.
  • 4) SIGN (June 2020). Management of osteoporosis and the prevention of fragility fractures

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.